The Associate Press (AP) reports that The National Highway Traffic Administration (NHTSA) has demanded Chrysler Group LLC to expand its geographic borders of a former recall that occurred in June 2014. Chrysler is to report said recall to designated areas by Monday, December 1.
About the Former Chrysler Recall
Chrysler Group, LLC recalled 371,000 vehicles in June 2014. The recall included:
- 2003-2008 Dodge Ram pickups
- 2004-2008 Dodge Durangos
- 2007-2008 Chrysler Aspens
- 2005-2008 Chrysler 300s
- 2005-2008 Dodge Dakota pickups
- 2006-2007 Mitsubishi Raiders pickups
The recall was exclusive to the listed vehicles in Florida, Hawaii, Puerto Rico and U.S. Virgin Islands.
Takata Corporation informed that manufactured airbags in said vehicles are defective in areas of high humidity, risking rupture of inflators. This defect provides a serious risk of injury and/or death.
About the Chrysler Recall Expansion
- NHTSA has criticized Chrysler for their lack of response to safety concerns in past recalls. Recently, they were reprimanded for slow moving repairs of 1.57 million Jeep SUVs.
- In November 2014, Takata informed Chrysler that the airbag recall is relevant in highly humid areas other than those that Chrysler had designated for the recall.
- Chrysler is to expand its recall to southern Georgia, Guam, Saipan, American Samoa and coastal areas of Alabama and Louisiana.
- Although Chrysler announced that they will inform affected consumers of the recall by December 19th, NHTSA has been firm in their deadline of December 1st.
- One injury associated with Takata air bags and Chrysler vehicles has been reported.
Share this article:
Five students from Texas A&M University were injured Sunday evening when their vehicle collided with a pickup near Cleveland, Texas.
About the Cleveland Accident
ABC 13 News reports the crash occurred on Texas 105 near Penny Road around 8:30 pm.
The students were traveling westbound in a 2011 Hyundai Sonata when their vehicle was struck by a 2002 Chevrolet pickup that had drifted across the median. The driver of the Sonata attempted to avoid the pickup, but struck the vehicle’s passenger side.
Three of the students were transported to area hospitals and are listed in stable condition. 22-year-old Akshay Jain and 24-year-old Ishan Bajaj were flown to Memorial Herman Hospital in Houston with critical injuries.
The driver of the pickup, 25-year-old Ramon Polawco, was taken to an area hospital and is said to be in stable condition.
Texas Car Crash Statistics
- The Texas Department of Transportation (TxDOT) recorded 3,377 traffic related fatalities in 2013.
- 1,883 of these deaths occurred in rural areas, and 523 deaths were linked to head-on collisions.
- 232,041 people were injured in auto accident in Texas in 2013.
- Based on available crash data for 2013, TxDOT estimates that one person was killed in an auto accident in Texas every 2 hours and 36 minutes.
Share this article:
The U.S. Food and Drug Administration’s (FDA’s) Anesthetic and Analgesic Drug Products Advisory Committee has concluded that epidural steroid injections (ESIs) should be contraindicated for transforaminal injections in the cervical region for the treatment of back pain.
ESIs Linked to Irreversible Adverse Events and Death
According to Medscape, committee members came to an agreement that the injection of particulate steroids in to the cervical region by a transforaminal approach can result in an increased risk of serious and irreversible neurological events.
Adverse events considered by committee members included:
- Spinal cord infarction
According to one panel member, James Eisenach, MD, professor of anesthesiology and physiology and pharmacology at Wake Forest School of Medicine in Winston-Salem, North Carolina, the occurrence of such events is supported by theoretical evidence as well as data from animal testing and patient reports.
What is a Transforaminal Approach?
A transforamal epidural steroid injection is a process in which medication is injected into a small lateral opening between to vertebrae. This opening is known as the foranimae.
While such injections can be used at the cervical, thoracic, and lumbar levels, committee members limited their concerned with the injections completed in the cervical area.
Members voted 15 to 7 there are clinical situation in which contraindications to ESIs are warranted. Other members believed a warning on the product label would have been sufficient.
Share this article: